• Trifluoperazine 2HCl: Applied Use-Cases in Dopamine D2 Modul

  2026-05-02

  Trifluoperazine 2HCl is redefining dopaminergic signaling research with its sub-nanomolar potency and robust solubility profile. Recent breakthroughs illustrate its dual value in both neuropharmacology and immune modulation, making it an indispensable tool for dissecting dopamine D2 pathways and macrophage function.

• Faropenem Sodium: Transporter Biology and Next-Level Assay D

  2026-05-01

  Explore Faropenem sodium as a penem antibiotic with unique transporter-mediated pharmacokinetics. This article reveals how Npt1 biology drives smarter assay design and unlocks new research frontiers.

• Dehydroepiandrosterone: Mechanistic Insights for Translation

  2026-05-01

  This thought-leadership article bridges advanced mechanistic science with actionable strategy for translational researchers working with Dehydroepiandrosterone (DHEA). Drawing on the latest literature and validated protocols, it explores DHEA’s unique bioregulatory roles in neuroprotection, apoptosis inhibition, and ovarian function, while providing implementation guidance and context on clinical relevance. The discussion is anchored in recent findings on inflammation-driven granulosa cell apoptosis in PCOS and integrates evidence from both peer-reviewed research and practical workflow recommendations.

• Rewiring Cancer Metabolism: PKM2 Inhibitor (Compound 3k) in

  2026-04-30

  This article provides a thought-leadership perspective for translational researchers on the emerging landscape of PKM2 inhibitor (compound 3k) as both a cancer cell metabolism disruptor and an immunometabolic modulator. By weaving together mechanistic insights, recent peer-reviewed findings, and strategic guidance, it highlights new translational opportunities—from oncology to inflammation—while illustrating protocol nuances and future outlooks. The discussion uniquely bridges oncology and immunometabolism, referencing key literature and APExBIO’s product leadership.

• Rotenone as a Precision Tool for Unraveling Mitochondrial St

  2026-04-30

  Explore how Rotenone, a mitochondrial Complex I inhibitor, enables next-generation autophagy and neurodegenerative disease research. This in-depth analysis reveals new mechanistic insights and assay strategies beyond conventional protocols.

• Targeted Amikacin Delivery to Mycobacterial Granulomas via D

  2026-04-29

  This study introduces a dendritic cell-based strategy for targeted delivery of Amikacin (BAY416651) into granulomas formed during Mycobacterium avium infection in mice. The approach achieves high local antibiotic concentrations at infection sites while minimizing systemic exposure, addressing long-standing challenges in treating recalcitrant nontuberculous mycobacterial infections.

• Amphotericin B (SKU B1885): Reliable Antifungal for Reproduc

  2026-04-29

  This article guides biomedical scientists through practical challenges in cell-based antifungal assays, illustrating how Amphotericin B (SKU B1885) from APExBIO delivers reproducible, data-validated solutions. Drawing on literature, comparative product analysis, and protocol optimization, it demonstrates why this polyene antifungal antibiotic is a cornerstone for sensitive, reliable fungal infection research.

• Reliable Protein Stability: Protease Inhibitor Cocktail (100

  2026-04-28

  Explore how Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) (SKU K4003) addresses protein degradation challenges in advanced cell and tissue assays. This article delivers scenario-driven guidance for biomedical researchers, highlighting workflow optimization, scientific evidence, and practical vendor selection criteria for reproducible, high-sensitivity results in protein analysis.

• Balsalazide Disodium Dihydrate: Evidence, Mechanism, and Use

  2026-04-28

  Balsalazide disodium is a water-soluble anti-inflammatory compound and 5-aminosalicylic acid prodrug. It is validated for rapid induction of remission in mild to moderate ulcerative colitis and is widely used in inflammation research. Its colon-targeted activation and favorable safety profile make it a robust choice for immunology assays and IBD models.

• Dehydroepiandrosterone (DHEA): Neuroprotection and Ovarian R

  2026-04-27

  Explore the multifaceted research utility of Dehydroepiandrosterone (DHEA) as a neuroprotection agent and modulator of ovarian function. This in-depth analysis integrates advanced mechanisms, protocol parameters, and new insights linking ER stress, apoptosis inhibition, and granulosa cell resilience.

• FITC-Concanavalin A (ConA) Conjugate: Practical Lab Guidance

  2026-04-27

  FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose moieties on cell surfaces, addressing the challenge of specific carbohydrate identification in immunofluorescence and flow cytometry workflows. It is not suitable for non-carbohydrate binding applications or use beyond its defined stability and storage parameters.

• Biomimetic Chromatography for Modeling Lung Drug Permeabilit

  2026-04-26

  This study evaluates biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane chromatography (IAM-LC), each coupled with mass spectrometry, for their effectiveness in modeling pulmonary permeability of pharmaceuticals. The work demonstrates the strengths and limitations of each method and offers validated parameters for high-throughput permeability screening in drug development.

• Technical Guide: 0.4% Trypan Blue Solution for Cell Viabilit

  2026-04-25

  0.4% Trypan Blue Solution provides a reproducible method for distinguishing live and dead cells during cell counting, viability assessment, and cytotoxicity assays. It is intended strictly for research use where membrane integrity discrimination is required and should not be used for diagnostic or clinical applications. Researchers should adhere to recommended workflows to ensure reliable and interpretable results.

• 3D Organoid-Fibroblast Co-Culture Models Reveal PDAC Chemore

  2026-04-24

  Schuth et al. introduce a patient-derived 3D organoid-fibroblast co-culture system that directly models stroma-mediated chemoresistance in pancreatic cancer. Their approach uncovers tumor-stroma interactions and transcriptional programs responsible for reduced drug sensitivity, providing a robust foundation for improved therapeutic evaluation and mechanistic studies.

• Low-Affinity Blockade of N-Type Ca Channels by v-Agatoxin-IV

  2026-04-24

  Sidach and Mintz’s study re-examines the selectivity of the spider toxin v-Agatoxin-IVA, revealing that at micromolar concentrations, it incompletely blocks neuronal N-type calcium channels, complicating its use for distinguishing P- and Q-type Ca channels pharmacologically. These findings refine the interpretation of toxin-based channel classification and impact the design of experiments probing calcium channel subtypes in neurophysiology.

11242 records 1/750 page Next 12345 下5页 Last page